News about Global Pharma

Champalimaud Foundation to Leverage Lonza Platform to Advance Cell Therapy

Champalimaud Foundation, a biomedical clinical research organization carrying out research and cutting-edge clinical development and discoveries that benefit people, and Lonza have announced the installation of Lonza’s MODA-ES Platform at the Champalimaud Clinical Centre in Lisbon, Portugal.

Global Pharma | 13/08/2024 | By Aishwarya |  880

Biosyngen Gets FDA Approval for BRG01 for Phase II Clinical Trial

Biosyngen has announced that the US Food and Drug Administration (FDA) has approved its BRG01, an EBV-specific CAR-T cell therapy, to proceed with a pivotal Phase lI clinical trial.

Global Pharma | 13/08/2024 | By Aishwarya |  487

Granules India Gets ANDA Approval for Trazodone Tablets

Granules now has 65 ANDA approvals from the US FDA (64 final approvals and 1 tentative approval). The current annual US market for Trazodone tablets is approximately USD 128 Million.

Global Pharma | 12/08/2024 | By Aishwarya |  858

Samsung Biologics Joins Pharmaceutical Supply Chain Initiative as Supplier Partner

Samsung Biologics, a global contract development and manufacturing organization (CDMO), has joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner.

Global Pharma | 08/08/2024 | By Aishwarya |  689

Valeo Pharma Announces Appointment of New CEO

Valeo Pharma Inc. has announced that the company’s Chief Development Officer, Al Moghaddam, has been appointed to succeed retiring CEO Steve Saviuk.

Global Pharma | 07/08/2024 | By Aishwarya |  1259

Gland Pharma Reports 16 Percent YoY Revenue Growth in Q1FY25

Gland Pharma has revealed its financial results for the first quarter of FY25, ending June 30, 2024.

Global Pharma | 07/08/2024 | By Aishwarya |  679

Antengene Gets Malaysian Regulatory Agency Approval for XPOVIO Commercialization

Antengene has announced that Malaysian National Pharmaceutical Regulatory Agency has approved a New Drug Application (NDA) for XPOVIO (selinexor).

Global Pharma | 06/08/2024 | By Aishwarya |  689

Skanray Partners with Tata Elxsi to Power Surgical Imaging Technology

Skanray has selected Tata Elxsi as a strategic partner for advanced surgical imaging core technology and software platform development.

Global Pharma | 05/08/2024 | By Aishwarya |  747

ASPA Delivers Keynote at ASIA Security Conference and Exhibition

The Authentication Solution Providers’ Association (ASPA) has announced that Puneet Maithani, Associate Director of Industry Affairs has delivered a compelling keynote address titled ‘ASPA: Leading the Fight Against Counterfeiting and Ensuring Product Authenticity’ at the ASIA Security Conference & Exhibition.

Global Pharma | 05/08/2024 | By Aishwarya |  1038

Anivive Bags NIAID Contract Worth Up to USD 33 Million to Progress Valley Fever Vaccine

Anivive Lifesciences Inc. has announced that the National Institute of Allergy and Infectious Diseases (NIAID) has awarded Anivive a new contract worth up to USD 33 million to support the development of a vaccine against the fungus Coccidioides, which causes Valley Fever.

Global Pharma | 03/08/2024 | By Aishwarya |  834